Utama › Mielofibrosis › New York › New York City
Kajian klinikal Mielofibrosis di New York City, NY
18 kajian untuk Mielofibrosis sedang mencari peserta di lokasi dalam dan sekitar New York City (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
Mengambil pesertaFasa 1/2
- Icahn School of Medicine at Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medical Center, New York
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
Mengambil pesertaFasa 3
- Memorial Sloan Kettering Cancer Center, New York
- Icahn School of Medicine at Mount Sinai, New York
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
Mengambil pesertaFasa 2
- NYP/Weill Cornell Medical Center, New York
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
Mengambil pesertaFasa 1/2
- Memorial Sloan Kettering Cancer Center, New York
- Icahn School of Medicine at Mount Sinai, New York
- Montefiore, New York
A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)
Mengambil pesertaFasa 1
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering, New York
- Icahn School of Medicine at Mount Sinai, New York
A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
Mengambil pesertaFasa 1
- Icahn School of Medicine At Mount Sinai, New York
A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis
Mengambil pesertaFasa 1/2
- Memorial Sloan Kettering Cancer Center, New York
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
Mengambil pesertaFasa 1
- Memorial Sloan Kettering Cancer Center, New York
- Mount Sinai School of Medicine, New York
- Weill Cornell Medicine, New York
Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)
Mengambil pesertaFasa 2
- Ruttenberg Treatment Center, New York
- Memorial Sloan Kettering Cancer Center, New York
- NewYork-Presbyterian/Weill Cornell Medical Center, New York
Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis
Mengambil pesertaFasa 2
- GSK Investigational Site, New York
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
Mengambil pesertaFasa 1
- Icahn School of Medicine At Mount Sinai, New York
- Memorial Sloan Kettering Cancer Center, New York
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Mengambil pesertaFasa 2
- Memorial Sloan Kettering, New York
A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
Mengambil pesertaFasa 2
- Weill Cornell Medicine NewYork-Presbyterian, New York
MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)
Mengambil pesertaKajian pemerhatian
- Memorial Sloan Kettering Cancer Center, New York
MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial
Mengambil pesertaFasa 2
- Ruttenberg Treatment Center, New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, New York
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
Mengambil pesertaFasa 3
- ICAHN School of Medicine at Mount Sinai, New York
Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs
Mengambil pesertaFasa 1
- Columbia University, New York
Kajian Mielofibrosis di bandar lain
- Houston, TX19 kajian
- Boston, MA12 kajian
- Durham, NC12 kajian
- Columbus, OH11 kajian
- Seattle, WA11 kajian
- Salt Lake City, UT10 kajian
- Miami, FL10 kajian
- Atlanta, GA9 kajian
- Baldwin Park, CA9 kajian
- Nashville, TN9 kajian
- Tampa, FL9 kajian
- Cleveland, OH9 kajian
Kajian lain di New York City
- Kanser Payudara136 kajian
- Kanser Paru-paru Bukan Sel Kecil121 kajian
- Kanser (semua jenis)109 kajian
- Kanser Prostat103 kajian
- Kanser Metastatik93 kajian
- Kanser Kolorektal78 kajian
- Kanser Ovari69 kajian
- Kanser Paru-paru60 kajian
- Mieloma Pelbagai60 kajian
- Kanser Pankreas60 kajian
- Kanser Endometrium52 kajian
- Leukemia Mieloid Akut51 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.